Locust Walk
corporateWebsite
Fund rating
0.0 / 35
0 published reviews
No per-dimension scores yet.
Published reviews
About
Evidence [7] is explicitly about how family office capital works for life science companies. For an AI-native longevity/biotech database at proof-of-concept stage seeking $100K-$500K, this makes Locust Walk a relevant financing intermediary target for family-office fundraising strategy or introductions.